Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Anavex Germany GmbH

Home Clinical Trial Sponsors and OrganizationsAnavex Germany GmbH

Anavex Germany GmbH

Am Klopferspitz 19a, Planegg, Bayern, Germany

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

4

4 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

100.0%

Trial Status Distribution

Active, not recruiting

4

100.0%

Clinical Trials

Trials sponsored by this organization (4)

Phase I trial, Quotient Sciences code: QSC206403

Active, not recruiting

Jan 202312 participants

ANAVEX2-73 Extension Study for treatment in AD

Active, not recruiting

Oct 2021325 participants

The use of ANAVEX2-73 as a new therapeutic treatment for Patients with Rett Syndrome

Active, not recruiting

Feb 202030 participants

ANAVEX2-73 used for a new treatment in AD

Active, not recruiting

Nov 2019450 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials4
Approvals
News

Back to Organizations